In GC, IGF2BP1 is overexpressed, enhancing PD-L1 mRNA stability, which boosts PD-L1 expression and allows tumor cells to evade immune system attacks (Jiang et al., 2024; Tang et al., 2024). This evidence concerns the gene IGF2BP1 and neoplasm.